膀胱肿瘤合并前列腺增生手术治疗82例临床分析  

Clinical analysis on 82 cases of bladder tumor combined benign prostate hyperplasia treated with operation

作　　者：滕志刚[1] 李海波[1] 乔宝民[1] 徐勇[1] 

机构地区：[1]天津医科大学第二医院泌尿外科天津市泌尿外科研究所,天津300211

出　　处：《天津医科大学学报》2013年第4期326-328,共3页Journal of Tianjin Medical University

摘　　要：目的:探讨早期膀胱肿瘤合并前列腺增生同期手术治疗及影响预后因素。方法:回顾性分析经手术治疗的82例膀胱肿瘤合并前列腺增生病人资料,并做统计学分析。40例(1组)行同期经尿道膀胱肿瘤电切除术(TURBt)和经尿道前列腺电切除术(TURP),42例(2组)行单纯经尿道膀胱肿瘤电切除术(TURBt)。结果:两组病人术后肿瘤复发差异有统计学意义(P=0.010 9),术后3月随访1组残尿量显著减少(P<0.001)。结论:早期膀胱肿瘤合并前列腺增生若肿瘤体积小于3 cm、病理分期Ta、T1期、肿瘤未侵及肌层,可以同期行TURBt联合TURP,该术式并不增加膀胱肿瘤的复发及种植转移的概率。Objective： To discuss bladder tumor combined benign prostate hyperplasia （BPH） treatment and prognostic factors for simultaneous operation. Methods： Statistical analysis and retrospective analysis were used for analysis of the materials of 82 patients with bladder cancer merger prostatic hyperplasia among with 40 cases were simultaneous transurethral bladder tumor and prostate resection （group 1）, and 42 cases were transurethral bladder tumor （group 2）. Results： The significant differences in recurrence between the 2 groups were significant （P=0.010 9 ）. The postvoid residual urine volume significantly decreased in group 1 three months after surgery （P〈 0.001）. Conclusion： Simultaneous transurethral bladder tumor and prostate resection could be performed if tumor size is less than 3 era, at pathologic stage Ta, during T1 period, with nonmuscle invasive bladder cancer; this method does not increase the recurrence of bladder tumor or chance of planting transfer.

关 键 词：膀胱肿瘤 前列腺增生 外科治疗 复发 

分 类 号：R737.14[医药卫生—肿瘤]